Cited by 362Heart Failure Treatment and ManagementCardiac pacing and defibrillation studiesCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 250 of the 255 references it cites were found in a registry or an index.

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Open access

Maddox, Thomas M., Januzzi, James L., Allen, Larry A., Breathett, Khadijah, Brouse, Sara, Butler, Javed, Davis, Leslie L., Fonarow, Gregg C., Ibrahim, Nasrien E., Lindenfeld, JoAnn, Masoudi, Frederick A., Motiwala, Shweta R., Oliveros, Estefania, Walsh, Mary Norine, Wasserman, Alan, Yancy, Clyde W., Youmans, Quentin R.·2024·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2023.12.024

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2023.12.024

Cites

250 of 250 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citation
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Human agency in social cognitive theory.
Bandura, A. (1989) · American Psychologist · doi:10.1037/0003-066x.44.9.1175 · Cited by 8,263
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382

Flagged first, then by citations

Show all 255 references

5 of the 255 references couldn’t be matched to a known paper.

Research works printed but not linked: 12

Desai, 2019, Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial, JAMA, 1
Mann, 2020, Sacubitril/valsartan in advanced heart failure with reduced ejection fraction: rationale and design of the LIFE Trial, J Am Coll Cardiol HF, 8, 789
Solomon, 2020, Effect of dapagliflozin in patients with hfref treated with sacubitril/valsartan: the DAPA-HF Trial, J Am Coll Cardiol HF, 8, 811
DeFilippis, 2020, Considerations for heart failure during the COVID-19 pandemic, J Am Coll Cardiol HF, 8, 681
Daubert, 2019, NT-proBNP goal achievement is associated with significant reverse remodelings and improved clinical outcomes in HFrEF, J Am Coll Cardiol HF, 7, 158
Myhre, 2022, Early B-Type natriuretic peptide change in HFrEF patients treated with sacubitril/valsartan: a pooled analysis of EVALUATE-HF and PROVE-HF, J Am Coll Cardiol HF, 10, 119
McAlister, 2004, Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials, J Am Coll Cardiol, 44, 810
Vaduganathan, 2020, Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: The CHAMP-HF Registry, J Am Coll Cardiol HF, 8, 469
Berardi, 2020, Angiotensin-neprilysin inhibition in Black Americans: data from the PIONEER-HF Trial, J Am Coll Cardiol HF, 8, 859
Pandey, 2019, Frailty is interwined with heart failure: mechanisms, prevalence, prognosis, assessment and management, J Am Coll Cardiol HF, 7, 1001
Mozaffarian, 2016, Heart disease and stroke statistic - 2016 update: a report from the American Heart Association, Circulation, 133, e38
2023, Standards of Medical Care in Diabetes-2024, Diabetes Care, 47, Suppl 1

Sorted by citations

Items 101–200 of 325

The Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Implantable Cardioverter Defibrillator Shocks in Heart Failure Patients Undergoing Diuretic Therapy
Erbay, İ., Güdül, N. E., Köktürk, U., Aladağ, P., Kandazoglu, M., & Avcı, A. (2024) · Medical Principles and Practice · doi:10.1159/000542172 · Cited by 2
Subclinical hypothyroidism: a new predictor of heart failure with improved ejection fraction in HFrEF patients
Zhou, H., Wang, Q., Liu, Z., Wu, G., Zhou, W., Yang, D., & Chen, K. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03827-w · Cited by 2
Global research trends on DPP-4 inhibitors and cardiovascular outcomes: a comprehensive bibliometric analysis
Amini‐Salehi, E., Hasanpour, M., Alotaibi, A. S., Rashidian, P., Hashemi, S. M. H., Nasrollahizadeh, A., Letafatkar, N., Saberian, P., Amani‐Beni, R., & Shanbehzadeh, N. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003089 · Cited by 3
Heart Failure in Black Populations: Epidemiology, Pathophysiology, and Treatment Disparities
Islam, K. N., Islam, R. K., Nguyen, I. D., Magherahabed, Y., Pirzadah, H., & Rashid, M. B. (2025) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-025-02371-3 · Cited by 2
Comparative Effectiveness of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors Versus Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) in Heart Failure With Reduced Ejection Fraction: A Systematic Review
Singh, P., Sunkara, A., Muskan, F., Lohana, K. V., Khan, M., Al-Deir, S. S., & Abbas, T. (2025) · Cureus · doi:10.7759/cureus.83166 · Cited by 2
Clinical outcomes of sacubitril-valsartan versus angiotensin converting enzyme inhibitor or angiotensin receptor blocker among patients with heart failure and ejection fraction at/less than 60 %: A retrospective, observational, parallel cohort, multi-group study
Albert, N. M., Bena, J., Morrison, S. L., Williams, J. B., Faulkenberg, K. D., Khairnar, R. R., & Martyn, T. (2025) · Heart & Lung · doi:10.1016/j.hrtlng.2025.04.027 · Cited by 2
Heart Failure with Reduced Ejection Fraction
Barkoudah, E., & Yancy, C. W. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.04.010 · Cited by 2
Self-citation
Advancements and challenges in pediatric dilated cardiomyopathy: a comprehensive review of current approaches and future directions
López-Guillén, J. L., Esmel-Vilomara, R., Rodoman, I., Constante, A. D., Kendall, I. S., Freixa‐Benavente, A., Diaz‐Gil, D., Cantarutti, N., Moscatelli, S., & Jeewa, A. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06263-w · Cited by 2
Clinical and economic analysis of the use of the medicinal product dapagliflozin in patients with chronic heart failure and type 2 diabetes mellitus
Zhuravleva, M. V., Gagarina, J. V., & Marin, T. V. (2024) · Diabetes Mellitus · doi:10.14341/dm13147 · Cited by 1
Comprehensive review of the heart failure management guidelines presented by the American College of Cardiology and the current supporting evidence
Lazareva, L., Shubrook, J. H., & Dhond, M. R. (2024) · Journal of Osteopathic Medicine · doi:10.1515/jom-2024-0071 · Cited by 1
Remote monitoring of patients with chronic heart failure: a non invasive approach
Emelianov, A. V., Kozhevnikova, M. V., Анатольевна, Ж. Е., Panova, A. L., Privalova, E. V., & Belenkov, Y. N. (2024) · Digital Diagnostics · doi:10.17816/dd633033 · Cited by 1
Heart Failure in Brazil: How Can We Improve its Natural History?
Ferrari, F., Rossi, A. P., & Santander, I. R. M. F. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240644i · Cited by 1
Vericiguat Adherence for Heart Failure With Reduced Ejection Fraction in Routine Clinical Care in the U.S.
Ikram, N., Bhatt, A. S., Vaduganathan, M., & Desai, R. J. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.01.013 · Cited by 1
Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspective
Shafrin, J. T., Wang, S., Kim, J., & Sikirica, S. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2025.31.4.386 · Cited by 1
Prescription Drug Coverage of Guideline-Directed Medical Therapy for People Living with Heart Failure with Reduced Ejection Fraction in Canada
Cowan, S., Kosar, L., Poon, S., Bains, M., Costigan, J., Ducharme, A., Gewarges, M., Groulx, S., MacFarlane, K., Nagpal, S., et al. (2025) · CJC Open · doi:10.1016/j.cjco.2025.05.018 · Cited by 1
Improving Medication Adherence in Heart Failure Through Pharmacist-Led Patient Education: Protocol for a Mechanism-Based Study of Information, Motivation, and Behavioral Skills
Chien, T.-C., Weng, S.-E., & Hsu, W.-T. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s527419 · Cited by 1
Prognostic significance of diastolic hypotensive episodes in patients stabilized after acute heart failure
Joo, H. J., Hong, S. J., Yu, C. W., Shin, S. Y., & Kim, E. J. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.06.036 · Cited by 1
Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor–Neprilysin Inhibitor
Iacoviello, M., Sarullo, F. M., Bilato, C., Correale, M., Gesaro, G. D., Driussi, M., Passantino, A., Villani, A., & Lenarda, A. D. (2025) · Cardiac failure review · doi:10.15420/cfr.2024.39 · Cited by 2
Chest CT-based analysis of radiomic and volumetric differences in epicardial adipose tissue in HFrEF patients with and without AF
Song, X.-Y., Ma, Y., Han, J.-M., Xie, Q., Zhang, H., Ma, Y.-H., Hu, J.-F., & Yang, A.-R. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05056-1 · Cited by 1
Prescription Patterns of Sacubitril/Valsartan in an Outpatient Population Diagnosed with Heart Failure with Reduced Ejection Fraction After a Recent Hospitalization
Roustan, D., Bothorel, H., & Kherad, O. (2025) · Epidemiologia · doi:10.3390/epidemiologia6030055 · Cited by 1
Cardiac Dual‐Targeting Nanocatalysts for Heart Failure Therapy by Breaking the ROS–Inflammation Positive Feedback
Du, H., Ma, D., Zhang, X., Yu, W., Lin, R., Lü, J., Na, Y., Sun, D., Zhu, P., Liu, P., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503020 · Cited by 1
Building CONFIDENCE in Upfront Combination Therapy Across Cardio-Kidney-Metabolic Syndrome
Agarwal, R., & Vaduganathan, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.042 · Cited by 1
Cardiomyopathy in valosin-containing protein multisystem proteinopathy: Evaluation, diagnosis, and management
Chan, J. M., Romano, C., Lee, A. Y., Wang, S. C., Lombardo, D. M., Kamdar, F. D., Dora, M., Khan, S., Mammen, P. P. A., & Kimonis, V. E. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100644 · Cited by 1
A multicomponent, high-intensity, patient-centered care intervention to optimize transitional care coordination for complex multimorbid people: a pre-post design
del Pino‐Sedeño, T., de León, B. G., Hernández, M. G., Olmedo, P. C., Melián, Y. S. R., Hernández, V. M., Bautista, E. G., Arraez, E. B., Cruz, S. B., Abrante-Luis, A., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1650973 · Cited by 1
The calcium awakens: new insights in cardiac gene therapy
Santulli, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1738693 · Cited by 1
Current practice and perceptions on the use of mineralocorticoid receptor antagonists in the management of heart failure: A cross-sectional study among Indian physicians
Garg, R., Sonawala, S., Banerjee, S., Kapoor, A., Pande, A., Sharma, A. K., Solanki, D., Santhoshkumar, P. K., Francis, F., Zalte, N., et al. (2025) · Heart India · doi:10.4103/heartindia.heartindia_39_25 · Cited by 1
Advances in Diagnosis and Treatment of Acute and Chronic Heart Failure: A Comprehensive Review
Kenyon, C. R., Wyk, L. V., Flom, A. P., Ibrahim, R., Pham, H. N., Lakhdar, S., Iftikhar, M., & Abdelnabi, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020618 · Cited by 4
Cost-Effectiveness of N-terminal Pro B-type Natriuretic Peptide for Evaluation and Management of People With Type 2 Diabetes in the Perspective of Brazilian Private Healthcare System
Lemos, G., Neveux, P., Januzzi, J. L., Pop‐Busui, R., & Malachias, M. V. B. (2026) · Value in Health Regional Issues · doi:10.1016/j.vhri.2026.101588 · Cited by 1
Self-citation
All That Is Wide Is Not Ventricular Tachycardia: A Case Highlighting Supraventricular Tachycardia as an Alternative in Stable Wide Complex Tachycardia With Reversible Cardiomyopathy
Hlupeni, A., Haider, R., & Cooper, J. A. (2026) · Cureus · doi:10.7759/cureus.104485 · Cited by 1
Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of Obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors
Antza, C., Jordan, J., McGowan, B. M., Ciudin, A., Filippi-Arriaga, F., Hönemann, J., Jelacovic, A., Nilsson, P. M., Tsioufis, K. P., Doehner, W., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004285 · Cited by 1
Social Determinants of Health and Outcomes in Hospitalized Patients with Heart Failure With Preserved Ejection Fraction
Hurera, A., Skowronski, J. N., Zhu, J., Thoma, F. W., Magnani, J. W., & Hickey, G. (2026) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2026.03.024 · Cited by 1
Global trends and hotspots of left ventricular assist device from 1963 to 2024: a bibliometric analysis
Sun, H., Geng, D., Song, Y., Zhang, L., Shao, Y., & Zhang, W. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-04036-6 · Cited by 1
Comprehensive guideline-directed medical therapy strategies on health status outcomes in patients with heart failure: the LAQUA-HF randomised clinical trial
Shiraishi, Y., Ikemura, N., Ueda, I., Kohno, T., Nakano, S., Tanaka, T. D., Nagatomo, Y., Ikoma, T., Ono, T., Numasawa, Y., et al. (2026) · Heart · doi:10.1136/heartjnl-2025-327642 · Cited by 1
Cardiovascular outcome trials (CVOTs) in cardiorenal metabolic medicine: a decade of transformative progress (2016–2026)
Wen, S., Wang, C., Xu, Z., Chen, L., He, Y., Ren, Y., Yuan, Y., Li, Y., Dong, M., Gong, M., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03164-6 · Cited by 1
Clinical characteristics and five-year outcomes in a prospective Russian real-world heart failure cohort
Вачиковна, П. Н., Terteryan, T. A., Арманович, А. А., Arutyunov, A., Popova, A. A., Vorobyeva, N., Osipova, I. V., Zhetisheva, R., AUSHEVA, A., & Madonna, R. (2026) · Vascular Pharmacology · doi:10.1016/j.vph.2026.107612 · Cited by 1
Remission in diabetic kidney disease: current evidence and future directions
Reaume, M., & Tangri, N. (2026) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001197 · Cited by 2
Rethinking ejection fraction for anesthesiologists: a narrative review
Rabis, M., & Moldzio, P. (2026) · Perioperative Medicine · doi:10.1186/s13741-026-00690-5 · Cited by 1
Mechanisms, Magnitude, and Consequence of Acute Estimated Glomerular Filtration Rate Change With Guideline-Directed Medical Therapy Initiation in Heart Failure
Shafi, T., & Bobart, S. A. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.04.052 · Cited by 1
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Transcatheter Aortic Valve Replacement: A Real-World Propensity-Matched Analysis
Zahid, S., Ahmad, M., Salman, F., Zahr, F. E., & Golwala, H. B. (2026) · Structural Heart · doi:10.1016/j.shj.2025.100764 · Cited by 1
Artificial intelligence-driven design and optimization of mitochondria-targeted nanocarriers for chronic heart failure
Zhang, Z. F., Zhou, X., Wei, T., Meng, L., & Long, K. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1824349 · Cited by 1
From Nonobstructive Plaque to LAD Thrombosis in a 26-Year-Old Athlete
Zalam, M. A., Kholeif, Z. M., Afzaal, U., Khan, M. D., & Patri, R. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108124 · Cited by 1
Drug-induced hyperuricemia: multi-pathway regulation, causative drugs, and individualized management strategies
Xiong, B., Duan, C., Xu, S., Xu, S., Yang, C., He, D., & Luo, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1791120 · Cited by 1
Utilization Patterns and Barriers to Sodium–Glucose Cotransporter-2 Inhibitor Prescription in Patients with Heart Failure: Real-World Evidence from Saudi Arabia
Alfehaid, L., Alkhezi, O. S., Alrayes, R., Alsuwaylihi, A., Alharbi, A. I., Aldosari, B., & Badreldin, H. A. (2026) · Cardiology and Therapy · doi:10.1007/s40119-026-00458-4 · Cited by 1
Frailty and Congestion in Patients with Heart Failure: Clinical Interaction and Prognostic Implications
Rodríguez-Eguren, Á., Llevadot, J., Broseta, J. J., Izquierdo, L. R., Solé‐González, E., Castel, M., Rodríguez, J. J., Cuadrado‐Payán, E., Sandoval, E., Martínez-Chillarón, M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124715 · Cited by 1
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association
DiDomenico, R. J., Marrs, J. C., Bress, A. P., Denfeld, Q. E., Dobesh, P. P., Effron, M. B., Goyal, P., Onyebeke, C. O., Peterson, J. K., & Petrovic, M. (2026) · Circulation · doi:10.1161/cir.0000000000001459 · Cited by 1
Trajectory of liver-related events following incident cardiovascular disease in MASLD: A 15-year population-based cohort study
Lian, L., Chen, Q., Xia, T., Huang, C., Wei, Y.-X., Targher, G., Byrne, C. D., Sperling, L. S., Lip, G. Y. H., Pang, Y., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156692 · Cited by 2
Intrarenal venous flow improvement after vericiguat in worsening HFrEF: A prospective VExUS-based study
Gigante, A., Cusumano, G., D’Amato, A., Segato, C., Germanò, R., Brigato, C., Cascone, R., Giovagnoli, F., Myftari, V., Cianci, R., et al. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134682 · Cited by 1
Timing, Translation, and Preparedness
Tritschler, T., Fuster, V., Lawler, P. R., Farkouh, M. E., Marx, C. E., Neal, M. D., Sholzberg, M., Spyropoulos, A. C., Tong, S. Y. C., Muñoz‐Rivas, N., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.05.028 · Cited by 1
Precipitants of Acute Heart Failure: A State-of-the-art Review from an International Expert Group
Naidu, A. S., Chioncel, O., Bruno, J., Butler, J., Coats, A. J. S., Collins, S. P., Cotter, G., Davison, B. A., Fatima, Z., Geavlete, O. D., et al. (2026) · Cardiac failure review · doi:10.15420/cfr.2025.49 · Cited by 1
Self-citation
Prognostic Implications of the 2025 American Society of Echocardiography Guidelines for the Evaluation of Left Ventricular Diastolic Function in Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation
Iwakura, K., Hoshida, S., Tanaka, N., Okada, M., Seo, M., Yamada, T., Yano, M., Hayashi, T., Yasumura, Y., Nakagawa, Y., et al. (2026) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2026.08.026 · Cited by 1
Procedural Health Equity in Heart Failure: Meeting Patients Where They Are
Youmans, Q. R., Chuzi, S. E., Guerrero, M. E., & Naidu, S. S. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.05.019 · Cited by 1
Self-citation
Medication optimization clinic decreases hospitalizations and mortality for patients with heart failure with reduced ejection fraction
Coons, J. C., Kliner, J., Mathier, M. A., Mulukutla, S. R., Thoma, F. W., Sezer, A., & Keebler, M. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100470 · Cited by 1
Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy
Subramaniam, S., Hassan, S., Ünlü, O., Kumar, S., Zelle, D., Ostrominski, J. W., Nichols, H., Chasse, J., McPartlin, M., Twining, M., et al. (2024) · Population Health Management · doi:10.1089/pop.2024.0132 · Cited by 1
Insuficiência Cardíaca no Brasil: Como Podemos Melhorar sua História Natural?
Ferrari, F., Rossi, A. P., & Santander, I. R. M. F. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240644 · Cited by 1
An Unusual Case of 11αB ‐Crystallin ( CRYAB ) Mutation as a Cause of Dilated Cardiomyopathy With Restrictive Physiology: A Case Report and Focused Review of the Literature
Bueno, C. O. P., Cruz-Buitrago, R. H., Mariño, A., Andres, C. M. E., Meek, E. A., & Ríos, E. G. (2025) · Clinical Case Reports · doi:10.1002/ccr3.70213 · Cited by 1
In-Hospital Adverse Events in Heart Failure Patients: Incidence and Association with 90-Day Mortality
Yousufuddin, M., Yamani, M. H., DeSimone, D. C., Barkoudah, E., Tahir, M. W., Ma, Z., Badr, F., Gomaa, I. A., Aboelmaaty, S. A., Bhagra, S., et al. (2025) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2025.03.003 · Cited by 1
Self-citation
Clinical Practice Guidelines: Quality, Breadth, and Currency
Ryerson, C. J., Jennerich, A. L., Nici, L. L., Raghu, G., Ghazipura, M., Aaron, S. D., Cristea, A. I., Cruz, C. S. D., Drummond, M., Ehsan, Z., et al. (2025) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202501-097ps · Cited by 1
Target doses of guideline-directed medical therapeutic agents predicts response to cardiac resynchronization therapy
Kingma, T. J., Albeyoumi, H., Kolluri, M., Sapowadia, A., Mehta, A., Kholoki, O., Passey, S., Wakefield, D. B., & Husain, S. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02708-2 · Cited by 1
Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Ахыт, Б. А., Berkinbaev, S., Ложкина, Н. Г., Николаевич, А. С., Zyatkov, N., Игоревна, К. О., Koshum-Bayeva, K., Орумбасарович, П. М., Tuleutayev, R. M., & Kultanova, E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248938 · Cited by 1
RESHAPE HF2 Trial for Mitral Valve Edge-to-Edge Repair for Mitral Regurgitation in Heart Failure: More Information Without More Clear Answers
McGregor, W. E., D'Orsi, G., & Cormican, D. S. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.02.005 · Cited by 1
Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
Lopez, M., Severino, P., & Lax, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1607362 · Cited by 1
The Effectiveness of In-hospital Initiation Guideline-directed Medical Therapy on the Prognosis of Patients with Heart Failure after Acute Anterior Myocardial InfarctionPreprint
Wang, X., Lei, M., Wang, J., Sun, X., Li, C., Li, Y., Zhao, Z., & Xue, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4341948/v1
Cardiovascular Care in the United States
Ahmad, T., Desai, N. R., & Tabtabai, S. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.001
Review and adaptation of European Federation of Internal Medicine clinical guidelines on acute heart failure
Larina, V. N., Kokorin, K. V. A., Иванович, Л. В., & Suvorova, N. A. (2024) · Russian Journal of Cardiology · doi:10.15829/15604071-2024-5915
A Trajetória das Gliflozinas: Da Casca da Macieira à Redução de Mortalidade Total na Insuficiência Cardíaca
Marques, F., Valicelli, F. H., Tanaka, D. M., & Simões, M. V. (2024) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20240027 · Cited by 1
The Trajectory of Gliflozins: From Apple Tree Bark to Reduced Overall Mortality in Heart Failure
Marques, F., Valicelli, F. H., Tanaka, D. M., & Simões, M. V. (2024) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20240027i
Reverse myocardial remodeling according to cardiac magnetic resonance imaging in patients with heart failure and atrial fibrillation receiving dapagliflozin
Saipudinova, K. M., Uskach, T. M., Shariya, M. A., Ustyuzhanin, D. V., & Tereshchenko, S. N. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-4090
Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure
Laimoud, M. H., & Raslan, I. R. (2024) · World Journal of Cardiology · doi:10.4330/wjc.v16.i11.665
Atrial Fibrillation in Heart Failure
Şahin, E., & Oto, A. (2024) · Cardiology and cardiovascular medicine. · doi:10.5772/intechopen.1006110
Identifying Demographic and Clinical Determinants of Ischemic Workup in Patients with Heart Failure
John, K. M., Wenn, P., Hai, O. Y., Zeltser, R., & Makaryus, A. N. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237279
Efeitos comparativos de IECA, BRA, Espironolactona e Sacubitril-Valsartan em pacientes com insuficiência cardíaca com fração de ejeção reduzida, com foco em mortalidade, hospitalizações e qualidade de vida
da Silveira, A. A. T., de Almeida, F. G. C., de Rezende, F. C., Miranda, L. L., Nassif, C. M., Carneiro, G. A., de Almeida, M. M. P., & Coutinho, M. P. J. M. (2024) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.17n.13-372
DRUG AND CARDIAC RESYNCHRONIZATION THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE (LITERATURE REVIEW)
Ахыт, Б. А., Ложкина, Н. Г., Berkinbayev, S., Орумбасарович, П. М., Кошумбаева, К. М., Mussagaliyeva, A., Junusbekova, G., Alieva, G., & Николаевич, А. С. (2024) · Медико-фармацевтический журнал «Пульс» · doi:10.26787/nydha-2686-6838-2024-26-12-35-45
COVID-19 Has Gone, But Not Its Cardiac Sequela: A Case Report
Mohammad, M., & Laksono, S. (2024) · AVERROUS Jurnal Kedokteran dan Kesehatan Malikussaleh · doi:10.29103/averrous.v10i2.19163
Implementation of an adherence pharmacy referral protocol for patients taking sacubitril/valsartan
Perry, B., Jakab, J., Robinson, B., McElhaney, E., Fallon, J. M., & Geyer, K. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2025.31.1.83
Pharmacotherapy of chronic heart failure - essential summary for pharmacists
Monhart, Z. (2025) · Česká a slovenská farmacie · doi:10.36290/csf.2024.039
Ischemic heart failure etiology: A misleading definition?✰.
Schmitt, A., Behnes, M., Akin, I., & Schupp, T. (2025) · European journal of internal medicine · doi:10.1016/j.ejim.2025.02.032
Overcoming Financial Barriers to Optimal Guideline-Directed Medical Therapy for Patients With Heart Failure
Campbell, R. J., Kliner, J., Goetze, H., & Coons, J. C. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2024.102994
Effects of a Cloud-Based Synchronous Telehealth Program on Valvular Regurgitation Regression: Retrospective Study
Yang, L., Wu, C., Lee, J., Wang, W. K., Chen, Y., Huang, C., Hung, C., Chiang, K.-C., Ho, Y., & Wu, H. (2025) · Journal of Medical Internet Research · doi:10.2196/68929
Is It Safe to Initiate/Optimize the Medication of HFrEF Patients During Hospitalization for Acute Decompensation?
Christodorescu, R., Brie, D. M., Brie, A. D., Mornoş, C., Dragan, S. R., Luca, C. T., Dărăbanțiu, D., & Tîrziu, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082664
The Contribution of Digital Remote Monitoring to Improving the Effectiveness of Treatment in Patients with Chronic Heart Failure with Reduced Ejection Fraction: data after a 6-week follow-up period (Preprint)Preprint
Kozhevnikova, M. V., Emelianov, A., Анатольевна, Ж. Е., Pavlov, N. A., Khabarova, N. V., & Belenkov, Y. N. (2025) · doi:10.2196/preprints.76963
Navigating the CKM Conundrum: An Integrated Approach to Cardiovascular, Kidney, and Metabolic Health
Cross, L. V., Eichler, C., Jones, E. J., & Mcdaniel, L. (2025) · ADCES in Practice · doi:10.1177/2633559x251333384
Readmission Rates in Reduced Ejection Fraction Heart Failure Patients on Triple Guideline-Directed Medical Therapy at Hospital Discharge
Woodruff, A. E., Haight, O., Maj, M., Mills, K., & Chilbert, M. R. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251336751
Combined Respiratory and Heart Failure after Chlorine Exposure: A Rare Case Report
Cho, S., Chu, H., Leo, A., & Yeh, S. (2025) · Journal of Clinical Question · doi:10.69854/jcq.2025.0017
Varón de 64 años con múltiples factores de riesgo cardiovascular con palpitaciones y disnea paroxística nocturna
Barros, A. L., Morán, J. S., Arribas, D. G., Ruiz-Saavedra, A., González, C. T., & Lledó, A. G. (2025) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2025.06.018
Insuficiencia cardíaca crónica con fracción de eyección ventricular izquierda reducida y ligeramente reducida
Morán, J. S., Delgado, J. G., Barros, A. L., Ruiz-Saavedra, A., González, C. T., & Lledó, A. G. (2025) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2025.06.011
Protocolo de manejo de la insuficiencia cardíaca crónica con fracción de eyección ventricular izquierda reducida
Morán, J. S., Delgado, J. G., Barros, A. L., Ruiz-Saavedra, A., González, C. T., & Lledó, A. G. (2025) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2025.06.016
Hypertension: a cardiovascular magnetic resonance imaging update
Manghat, N. E., Mitrousi, K., Rodrigues, J. C. L., Hart, E. C., Nightingale, A. K., & Hamilton, M. C. K. (2025) · Clinical Radiology · doi:10.1016/j.crad.2025.107035
"Youth Is a Disease that is Cured with Age"
Lerman, J. (2025) · Revista Argentina de Cardiología · doi:10.7775/rac.v93.i3.20895
Methamphetamine’s Devastating Scourge
Iqbal, S., Cordova, J. C., & Young, J. B. (2025) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1568
“Bridging Guidelines and Real World Barriers: Reflections on GDMT Optimization in Heart Failure”
Tahir, I., Shahbaz, H., & Khattak, A. (2025) · Clinical Cardiology · doi:10.1002/clc.70206
Effectiveness and safety of exercise-based cardiac rehabilitation (ExCR) during the vulnerable period in patients with acute decompensated heart failure (ADHF): a randomised controlled trial protocol
Ye, J., Zhao, L., Jiang, Y., Hu, L., Yang, L., Wang, Y., Ding, W., & Zheng, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102812
Case 27-2025: A 53-Year-Old Man with Embolic Stroke and Left Ventricular Apical Aneurysm
Stewart, G. C., Gong, J., Lorca, M. C., Blair, B. M., Coglianese, E. E., & Castillo, B. (2025) · New England Journal of Medicine · doi:10.1056/nejmcpc2412537
Achieved targeted heart rate following ivabradine therapy correlates with left ventricular reverse remodeling in non-ischemic dilated cardiomyopathy
Lee, J., Oh, J., Ha, J., Lee, C. J., & Kang, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-09352-w
Revisiting the Role of Tolvaptan in the Management of Hyponatraemia in Acute Heart Failure: Balancing Quality of Life and Cost With Tolvaptan Treatment
Olaogun, I., Young, E. E., & Anyim, O. B. (2025) · Cureus · doi:10.7759/cureus.93460
Calling All Geniuses
Kramer, C. M., Fry, E. T. A., & Morris, P. B. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.026
Delayed Presentation of Post-traumatic Coronary Artery Dissection Resulting in Acute Myocardial Infarction and Severe Left Ventricular Dysfunction Treated With Angioplasty and Stenting: A Case Report
Gupta, A. K., & Garg, N. (2025) · Cureus · doi:10.7759/cureus.94069
Does Age Matter? SGLT2 Inhibitors in Older Adults With Heart Failure
Daniel, V., & Vardeny, O. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013595
Predicting Early Diuretic Success in the Emergency Department: Operational and Pathophysiologic Implications of Urine Sodium and Conductivity
Rattanapitoon, S. K., La, N., Gordon, C. N., & Rattanapitoon, N. K. (2025) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2025.10.002
Long-Term Outcome and Quality of Life in Long-Term Noninvasive Ventilatory Support in Chronic Cardiac Disorders
Almeida, H., & Rodríguez-Alonso, B. (2025) · Noninvasive ventilation. The essentials · doi:10.1007/978-3-031-97449-6_48
Dapagliflozin in Heart Failure with Reduced Ejection Fraction (HFrEF): A Systematic Review of Its Mechanisms and Clinical Effectiveness
Karmawan, Z. N. P., Simorangkir, R. L. Y., & Kalalo, J. G. K. (2025) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v8i4.1121

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K. K., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., Masoudi, F. A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.022 · Cited by 872
Self-citation
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction
Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.393 · Cited by 554
Self-citation
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update
Hollenberg, S. M., Stevenson, L. W., Ahmad, T., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Morris, A. A., Page, R. L., II, et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.002 · Cited by 82
Self-citation
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
Yancy, C. W., Januzzi, J. L., Allen, L. A., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Jessup, M. L., Lindenfeld, J., Maddox, T. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.025 · Cited by 284
Self-citation
Management of Heart Failure With Preserved Ejection Fraction: 2026 ACC Expert Consensus Decision Pathway
Kittleson, M. D., Panjrath, G. S., Bates, K., Breathett, K. K., Dixon, D. L., Januzzi, J. L., & Mohammed, S. F. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.018 · Cited by 15
Self-citation

See all

Authors: Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K., Brouse, S., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., Masoudi, F. A., Motiwala, S. R., Oliveros, E., Walsh, M. N., Wasserman, A., Yancy, C. W., & Youmans, Q. R.
ORCID: Maddox, Thomas M.
Januzzi, James L.
Allen, Larry A.
Breathett, Khadijah
Butler, Javed
Davis, Leslie L.
Fonarow, Gregg C.
Ibrahim, Nasrien E.
Lindenfeld, JoAnn
Masoudi, Frederick A.
Walsh, Mary Norine
Yancy, Clyde W.
Youmans, Quentin R.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2024-04
Volume: 83
Issue: 15
Pages: 1444-1488
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2023.12.024
OpenAlex: W4392581840
Cited by: 362
References: 255
Citations by year: 2026: 181 · 2025: 133 · 2024: 48
FWCI: 100.60
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 380 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: heart failure with reduced ejection fraction, expert consensus, heart failure treatment, guideline recommendations
MeSH terms: Cardiology, Cardiovascular System, Heart Failure, Humans, Stroke Volume, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks